NAOV NanoVibronix: Operating Margin

NanoVibronix, Inc. (NAOV) generates revenue through the sale of PainShield and UroShield ultrasonic systems. The operating profit margin correlates with these streams, and its latest value is recorded as -351.80. Distribution efficiency is supported by external management of clinical trials, while a complete transition to factory outsourcing under strict patent control minimizes the company's production risks.
NanoVibronix, Inc. - analytical breakdowns and key metrics (NAOV)

Operating margin measures the efficiency of the core business, reflecting the share of earnings before interest and taxes in total revenue to assess internal profitability. By analyzing the adjusted operating margin, an investor can see the ability of NanoVibronix, Inc. (NAOV) to monetize its ultrasonic technologies for infection and pain therapy, converting innovative medical patches into actual operating cash flow.